Publisher
Springer Science and Business Media LLC
Subject
Pharmacology (medical),Pharmacology,General Medicine
Reference26 articles.
1. Ponikowski P, Voors AA, Anker SD et al (2016) 2016 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure. Eur Heart J 37:2129–2200. https://doi.org/10.1093/eurheartj/ehw128
2. Bui AL, Horwich TB, Fonarow GC (2011) Epidemiology and risk profile of heart failure. Nat Rev Cardiol 8:30–41
3. McMurray JJV, Packer M, Desai AS et al (2014) Angiotensin–neprilysin inhibition versus enalapril in heart failure. N Engl J Med 371:993–1004. https://doi.org/10.1056/NEJMoa1409077
4. Almufleh A, Marbach J, Chih S et al (2017) Ejection fraction improvement and reverse remodeling achieved with Sacubitril/Valsartan in heart failure with reduced ejection fraction patients. Am J Cardiovasc Dis 7:108–113
5. Januzzi JL, Prescott MF, Butler J et al (2019) Effects of angiotensin receptor/neprilysin inhibitor therapy on amino-terminal Pro-B-Type natriuretic peptide and cardiac remodeling in heart failure with reduced ejection fraction: the PROVE-HF Study. J Card Fail 25:937. https://doi.org/10.1016/j.cardfail.2019.11.004
Cited by
21 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献